ReviewJournal of clinical microbiology2005
Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Review in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 87 citations in OpenAlex.
- Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era.Mycopathologia · 2026Article
- Fungal brain abscesses caused byThe Egyptian journal of internal medicine · 2023Article
- Successful Treatment of Disseminated Disease Due to Highly Resistant Aspergillus calidoustus with a Novel Antifungal Therapy.Antimicrobial agents and chemotherapy · 2022Article
- Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient.Mycopathologia · 2020Article
- Aspergillus pseudodeflectus: a new human pathogen in liver transplant patients.BMC infectious diseases · 2018Article
- Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies.Antimicrobial agents and chemotherapy · 2015Article
- Update on Antifungal Drug Resistance.Current clinical microbiology reports · 2015Article
- Multi-resistant aspergillosis due to cryptic species.Mycopathologia · 2014Review
- Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.Antimicrobial agents and chemotherapy · 2013Article
- In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods.Antimicrobial agents and chemotherapy · 2013Article
- Invasive aspergillosis: resistance to antifungal drugs.Mycopathologia · 2012Review
- In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.Antimicrobial agents and chemotherapy · 2011Article
- New taxa in Aspergillus section Usti.Studies in mycology · 2011Article
- Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.European journal of medical research · 2011Review
- Emerging bacterial, fungal, and viral respiratory infections in transplantation.Infectious disease clinics of North America · 2010Review
- Invasive Aspergillosis of the Hand Caused by Aspergillus ustus: a Case Report.Hand (New York, N.Y.) · 2010Article
- Cerebral aspergillosis caused by Aspergillus granulosus.Journal of clinical microbiology · 2009Article
- Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus.Eukaryotic cell · 2008Article
- Aspergillus species identification in the clinical setting.Studies in mycology · 2007Article
- Polyphasic taxonomy of Aspergillus section Usti.Studies in mycology · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aspergillus ustus is an uncommon clinical species which is poorly susceptible to antifungals. We report two cases of A. ustus infections that occurred in allogeneic stem cell transplant recipients while they were receiving either voriconazole or caspofungin. Prolonged use of these new antifungal agents may increase the risk of the emergence of resistant organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.